Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $350.25. The company's market cap stands at 189.7B, with a P/E ratio of 24.53 and a dividend yield of 2.8%.
On 2026-04-01, Amgen(AMGN) stock moved within a range of $342.12 to $355.49. With shares now at $350.25, the stock is trading +2.4% above its intraday low and -1.5% below the session's peak.
Trading volume for Amgen(AMGN) stock has reached 3.72M, versus its average volume of 3.14M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
AMGN News
The FDA had asked Amgen to pull Tavneos from the U.S. market in January, citing some methodological concerns about a previous clinical trial and the risk of hep...
Teva Pharmaceutical Industries (NYSE:TEVA) received FDA approval for PONLIMSI, its denosumab biosimilar to Prolia. The company has also submitted regulatory ap...
...
Analyst ratings
53%
of 38 ratingsMore AMGN News
The Schwab U.S. Dividend Equity ETF (SCHD 0.59%) has a very simple strategy. It tracks an index that aims to hold the top 100 high-yielding dividend stocks. Tha...
Amgen (AMGN) announced that Repatha, when added to statins or other low-density lipoprotein cholesterol-lowering treatments, reduced the risk of first major adv...
Amgen (NasdaqGS:AMGN) released new VESALIUS-CV Phase 3 subgroup data on Repatha showing a significant reduction in first major cardiovascular events in high ris...
Advertisement What Amgen’s Recent Share Moves Signal for Investors Amgen (AMGN) has seen mixed recent returns, with gains over the past year but a decline ove...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has reported a key update on its Phase 3 ROCKET-Outpost study, which lo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.